Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 316.737 million compared to CNY 137.569 million a year ago. Operating income was CNY 33.440 million compared to operating loss of CNY 39.281 million a year ago. Net income was CNY 26.955 million compared to net loss of CNY 14.561 million a year ago. Basic earnings per share from continuing operations was CNY 0.08 compared to basic loss per share from continuing operations of CNY 0.05 a year ago.